Clinical Trials Directory

Trials / Completed

CompletedNCT03441009

Metabolism and the Activity of the Autonomic Nervous System in Patients With Paroxystic Sympathetic Hyperactivity, PSH

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Region MidtJylland Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Adult patients suffering from acquired brain damage run the risk of developing PSH. This group of patients is admitted to our unit, the Neurointensive Stepdown Unit, at Silkeborg Regional Hospital for intensive care and early neurorehabilitation. After weaning from intensive carethey are transferred to Hammel NeuroCentre. Aim is to assess whether HRV-derived variables in the frequency domain mirror therapeutic and/or nursing and/or pharmacologic interventions. To the extent clinically available BRS and metabolism are included in the assessment.

Detailed description

See report: Honore H, Eggertsen K, Sondergaard S: A study into the feasibility of using HRV variables to guide treatment in patients with paroxystic sympathetic hyperactivity in a neurointensive step-down unit. NeuroRehabilitation 2019, 44(1):141-155.

Conditions

Interventions

TypeNameDescription
OTHERPhysio-/occupational therapyPhysio-/occupational therapy, ADL

Timeline

Start date
2016-01-02
Primary completion
2020-10-01
Completion
2020-10-01
First posted
2018-02-22
Last updated
2021-09-24

Source: ClinicalTrials.gov record NCT03441009. Inclusion in this directory is not an endorsement.

Metabolism and the Activity of the Autonomic Nervous System in Patients With Paroxystic Sympathetic Hyperactivity, PSH (NCT03441009) · Clinical Trials Directory